Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 8:08 PM ET | Feedback | Site Changes | Help
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
View All Commentary (ENDP)
Recs
pennysplants (99.68) Submitted: 10/01/07 4:37 PM : Start Price: $30.31 ENDP Score: 16.21
Held in there pretty well today after bad news. Me likes. A value plus growth proposition.Overall, a strong, mature company with LOTS of cash. I don't think a little bad news here and there will really hold them back. I believe the management transition is going well. Expect a 20-30% return over 12 months. NOT a pocket rocket. But, an S&P outperformer in troubled times, me thinks.
Report this Post Replies: 2 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
pennysplants (99.68) Submitted: 3/10/08 11:48 AM
Recs: 0 | Rec This
I am concerned to learn that a lot of their cash is tied up in auction/illiquid securities. This might slow them down a good bit and make investors nervous. Won't help short term valuations, that's for sure.
Report this Post Reply
pennysplants (99.68) Submitted: 10/30/08 5:56 PM
Voltaren gel. Once only available as a pain pill. It has changed my father's life.